Effect of Exercises on Convergence Insufficiency in Individuals With Temporomandibular Disorders

Launched by UNIVERSITY OF NOVE DE JULHO · Feb 27, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how specific exercises might help people with Temporomandibular Disorder (TMD) and a condition called convergence insufficiency (CI), which affects how well the eyes work together to focus on nearby objects. TMD involves pain in the jaw and facial muscles, and researchers want to see if adding eye exercises to standard TMD treatments can improve symptoms. Participants will be divided into two groups: one will receive regular treatment for TMD, while the other will get both TMD treatment and eye exercises for 12 weeks.

To join the trial, individuals must be between 18 and 60 years old and have experienced facial pain for the past 6 months, with a pain level of at least 3 on a scale of 1 to 10. They should also have a diagnosis of myogenic TMD and convergence insufficiency. Throughout the study, participants will be evaluated before, immediately after, and again 3 and 6 months later to see how effective the treatment is. It's important to note that some people may not be eligible due to certain health conditions or medications. This trial is currently recruiting participants, and more information can be obtained if you’re interested.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 18 and 60 years;
• • Presence of pain in the facial region in the last 6 months;
• • Presence of pain, at least 3 on the numeric pain scale (END), in the Temporomandibular Joint and/or masticatory muscles and in the last 6 months;
• • Diagnosis of myogenic Temporomandibular Disorder, by DC/TMD;
• • Moderate and Severe Temporomandibular Disorder carrier, according to Fonseca's Anamnestic Index;
• • Presence of Insufficiency of Convergence according to Convergence Test (TC) and by Convergence insufficiency symptom Survey (CISS).
• Exclusion Criteria:
• • Permanent strabismus;
• • History of strabismus surgery;
• • History of cervical and/or craniofacial trauma/surgical procedure;
• • History of ocular nerve injury;
• • Neurological disorders;
• • disc disease ;
• • Systemic diseases;
• • Fibromyalgia diagnosis;
• • Previous treatments for TMD carried out in the last 3 months;
• • Previous treatments of Convergence Insufficiency with oculomotor therapy (no more than 2 months of treatment in the last year);
• • Occlusal treatment in progress;
• • Any ocular or systemic medication known to affect accommodation or vergence ;
• • Systemic diseases that affect ocular accommodation, vergence , and motility, such as multiple sclerosis, Graves' thyroid disease, myasthenia gravis, diabetes, and Parkinson's disease;
• • In continuous use of analgesics, anti-inflammatories, anxiolytics and/or antidepressants;
• • Pregnant women.